Cwm LLC Cuts Position in Molina Healthcare, Inc $MOH

Key Points

• Cwm LLC reduced its stake in Molina Healthcare by 7.6%, owning 16,359 shares valued at approximately $4.87 million after selling 1,345 shares during the second quarter.
• Molina Healthcare reported an EPS of $5.48 for the last quarter, which fell short of analysts' expectations, while its revenue exceeded predictions at $11.43 billion, marking a 15.7% increase year-over-year.
• Analysts have downgraded Molina's stock price targets, with Robert W. Baird lowering its target from $373 to $179, while the consensus rating remains a Hold with an average target price of $222.15.

Cwm LLC lessened its stake in Molina Healthcare, Inc (NYSE:MOH - Free Report) by 7.6% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 16,359 shares of the company's stock after selling 1,345 shares during the quarter. Cwm LLC's holdings in Molina Healthcare were worth $4,873,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Zions Bancorporation National Association UT bought a new stake in shares of Molina Healthcare in the 1st quarter worth approximately $29,000. Deseret Mutual Benefit Administrators raised its holdings in shares of Molina Healthcare by 60.7% in the 1st quarter. Deseret Mutual Benefit Administrators now owns 90 shares of the company's stock worth $30,000 after purchasing an additional 34 shares during the period. Elequin Capital LP raised its holdings in shares of Molina Healthcare by 170.6% in the 1st quarter. Elequin Capital LP now owns 92 shares of the company's stock worth $30,000 after purchasing an additional 58 shares during the period. Silver Oak Securities Incorporated bought a new stake in shares of Molina Healthcare in the 1st quarter worth approximately $34,000. Finally, Allworth Financial LP raised its holdings in shares of Molina Healthcare by 52.0% in the 1st quarter. Allworth Financial LP now owns 228 shares of the company's stock worth $72,000 after purchasing an additional 78 shares during the period. Institutional investors own 98.50% of the company's stock.

Molina Healthcare Stock Down 2.1%

MOH opened at $188.26 on Friday. The stock has a market cap of $10.20 billion, a PE ratio of 9.28 and a beta of 0.55. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.77. Molina Healthcare, Inc has a 52 week low of $151.95 and a 52 week high of $359.97. The business's fifty day simple moving average is $181.22 and its 200 day simple moving average is $245.68.

Molina Healthcare (NYSE:MOH - Get Free Report) last released its earnings results on Wednesday, July 23rd. The company reported $5.48 EPS for the quarter, missing analysts' consensus estimates of $5.50 by ($0.02). The firm had revenue of $11.43 billion during the quarter, compared to the consensus estimate of $10.94 billion. Molina Healthcare had a net margin of 2.60% and a return on equity of 27.72%. The firm's revenue was up 15.7% compared to the same quarter last year. During the same period in the prior year, the company earned $5.86 EPS. As a group, research analysts expect that Molina Healthcare, Inc will post 24.4 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Molina Healthcare news, Director Ronna Romney sold 700 shares of the company's stock in a transaction dated Wednesday, August 6th. The shares were sold at an average price of $153.74, for a total transaction of $107,618.00. Following the completion of the sale, the director directly owned 17,131 shares in the company, valued at $2,633,719.94. This represents a 3.93% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, COO James Woys purchased 10,000 shares of the business's stock in a transaction on Monday, August 4th. The shares were acquired at an average price of $155.94 per share, with a total value of $1,559,400.00. Following the completion of the transaction, the chief operating officer owned 74,331 shares of the company's stock, valued at approximately $11,591,176.14. This trade represents a 15.54% increase in their ownership of the stock. The disclosure for this purchase can be found here. 1.10% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

MOH has been the subject of a number of recent analyst reports. Robert W. Baird reduced their price target on shares of Molina Healthcare from $373.00 to $179.00 and set a "neutral" rating for the company in a research report on Friday, July 25th. The Goldman Sachs Group began coverage on shares of Molina Healthcare in a report on Tuesday. They issued a "neutral" rating and a $207.00 price target on the stock. Barclays decreased their price target on shares of Molina Healthcare from $186.00 to $185.00 and set an "equal weight" rating on the stock in a report on Thursday, September 4th. UBS Group decreased their price target on shares of Molina Healthcare from $260.00 to $180.00 and set a "neutral" rating on the stock in a report on Friday, July 25th. Finally, JPMorgan Chase & Co. decreased their price target on shares of Molina Healthcare from $272.00 to $184.00 and set a "neutral" rating on the stock in a report on Tuesday, July 29th. Three analysts have rated the stock with a Buy rating, twelve have given a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $222.15.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.